Dr. Xiaoyan Wang received her PhD Degree in Biology from Chinese Academy of Sciences, and MBA from Shanghai Advanced Institution of Finance (SAIF) of Shanghai Jiao Tong University. She was a product specialist of Beckman Coulter, a vice GM of Bioscience, Director of Chinese Academy of Sciences Biochemical Department, an investment manager of China-Singapore Suzhou Industrial Park Venture Capital, and Investment Director of Oriza Seed Fund Management Co.
During Dr. Wang’s career in China-Singapore Suzhou Industrial Park Venture Capital and Oriza Seed Fund Management Co., she led the investments in early-stage companies focusing on medical devices, pharmaceuticals and medical services, including Innovent Biologics, CF PharmaTech, Bowing Medical, Ryan Nano, Sealand Technology, Tennor Therapeutics, and etc. Most of these companies completed the next-round financing.
Dr. Wang has more than 10-year experience in the field of medical, and years of experience in equity investment especially in healthcare industry . Currently she serves as an MD and IC Member of GP Healthcare Capital.